Live better. Live longer.
Bristlecone Pacific is a venture capital fund investing in innovative companies with world-class teams, developing evidence-based solutions to extend healthy human lifespan.
We believe new interventions, backed by scientific evidence, will enable humans to control the biological aging process and be youthful at any age.
about anchor
Our Focus Areas
“It is not an unreasonable expectation for anyone who is alive and healthy today to reach 100 in good health - active and engaged at levels we’d expect of healthy 50-year olds today.”
Harvard Medical School genetics professor and “Lifespan” author, Dr. David Sinclair
team anchor
Meet The Team
Dan Eisenhardt
General Partner, Vancouver BC
Founder & CEO - FORM
Smart swim goggle start-up, ARR $5M, raised US $30M in funding, growing at 200% YoY
Co-Founder - Rhino Ventures
Western Canada’s leading early stage venture fund with C$168M AUM, Fund I achieved 11x TVPI and 61% gross IRR from 2015 to mid-2022
Co-founder & CEO - Recon Instruments (Intel)
Smart eyewear for sports, raised C$35M, acquired by Intel for C$175M in 2015. Became General Manager of Headworn Group with 1,300 people and $300M P&L
Investing and board experience
Invested in 30+ companies and served as board member in 7 of them.
Taken active role in over 10 end-to-end startup journeys from seed investor to exit
Lars Staal Wegner
General Partner, Copenhagen DK
AI and biotech executive
Former CEO of Evaxion Biotech (Nasdaq: EVAX) Grew company from 2 to 70 FTE, took multiple programs to clinical trials, led Nasdaq IPO
Leadership roles at Pfizer and Bavarian Nordic
Medical doctor
Capital markets and corporate development
Raised $200M+ via IPOs, follow-ons, venture rounds, HNI and grants.
Executed $3B+ in transaction value
Investing and board experience
Chairman: G-Mendel (AI and diagnostics)
Vice Chair: Gain and Co (robotics)
Vice Chair: How to Robot (robotics
Investor in Rhino Ventures, Myopax, Raffle AI, Plex Research, PII Guard, Codesealer, Recon Instruments, FORM
Rudi Airisto
Principal, Vancouver BC
Head of Business Planning & Corp Dev - Article
Grew sales from $200M in 2018 to $500M in 2021
Chief of Staff - Grow Technologies
Acquired by ATB Financial in 2019.
Head of Strategy, Wearables Group - Intel
Combined in-house and acquired wearable and AR/VR technology assets, spun out to Google.
VP Business Development - Recon Instruments
Led partnerships in multiple new verticals. Acquired by Intel in 2015.
Consultant - McKinsey & Company
Strategy, Ops, and Private Equity Due Diligence across USA & EMEA.
Investing experience
Investor in Rhino Ventures, Sepior, AdQuantic, Mendelian, InProTher, LifeGait, Stryd, Recon Instruments, FORM, Matterway, Keycafe
Dan Eisenhardt
General Partner, Vancouver BC
Founder & CEO - FORM
Smart swim goggle start-up, ARR $5M, raised US $30M in funding, growing at 200% YoY
Co-Founder - Rhino Ventures
Western Canada’s leading early stage venture fund with C$168M AUM, Fund I achieved 11x TVPI and 61% gross IRR from 2015 to mid-2022
Co-founder & CEO - Recon Instruments (Intel)
Smart eyewear for sports, raised C$35M, acquired by Intel for C$175M in 2015. Became General Manager of Headworn Group with 1,300 people and $300M P&L
Investing and board experience
Invested in 30+ companies and served as board member in 7 of them.
Taken active role in over 10 end-to-end startup journeys from seed investor to exit
Lars Staal Wegner
General Partner, Copenhagen DK
AI and biotech executive
Former CEO of Evaxion Biotech (Nasdaq: EVAX) Grew company from 2 to 70 FTE, took multiple programs to clinical trials, led Nasdaq IPO
Leadership roles at Pfizer and Bavarian Nordic
Medical doctor
Capital markets and corporate development
Raised $200M+ via IPOs, follow-ons, venture rounds, HNI and grants.
Executed $3B+ in transaction value
Investing and board experience
Chairman: G-Mendel (AI and diagnostics)
Vice Chair: Gain and Co (robotics)
Vice Chair: How to Robot (robotics)
Investor in Rhino Ventures, Myopax, Raffle AI, Plex Research, PII Guard, Codesealer, Recon Instruments, FORM
Rudi Airisto
Principal, Vancouver BC
Head of Business Planning & Corp Dev - Article
Grew sales from $200M in 2018 to $500M in 2021
Chief of Staff - Grow Technologies
Acquired by ATB Financial in 2019
Head of Strategy, Wearables Group - Intel
Combined in-house and acquired wearable and AR/VR technology assets, spun out to Google
VP Business Development - Recon Instruments
Led partnerships in multiple new verticals. Acquired by Intel in 2015
Consultant - McKinsey & Company
Strategy, Ops, and Private Equity Due Diligence across USA & EMEA
Investing experience
Investor in Rhino Ventures, Sepior, AdQuantic, Mendelian, InProTher, LifeGait, Stryd, Recon Instruments, FORM, Matterway, Keycafe
Investment Advisors
Ole Søeberg
Ole Søeberg runs Nordic Investment Partners, an advisory service for investing, fundraising and strategy sparring built on his 38+ years of experience in global financial markets. Board member in investment related organizations for the past 25 years.
Ole has a successful track record of identifying important growth trends early and investing ahead of the curve as the trend matures.
He has been Chairman of Danish Shareholders Association, board member of Carnegie World Wide, Skagen Funds, TGS Nopec, Precise Biometrics, and AC Vision Fund.
Ole has managed capital for AC Vision Fund and Skagenfunds in Norway as CIO and fund manager since 2011. From 1985 to 2011, he held various roles in equity research, investment management, and Investor Relations with leading Nordic companies such as Alfred Berg, Carnegie TDC, and Tryg Insurance.
Ole holds an MBA from Copenhagen Business School, and completed executive courses at IMD and INSEAD.
Yobbo Meshak
Yobbo Meshak has a successful track record of building companies and fostering collaboration within the biotech and technology industries. As an entrepreneur, he has founded and invested in several early stage business ventures. He has also helped European pharmaceutical companies expand their business in the Asia-Pacific market for over 19 years.
He has facilitated collaborations between companies, private investors, universities, and
governmental organizations for the development of innovative technologies.
Yobbo has worked with private equity investors throughout his career, and over the past 3 years alone, raised over $150M in funding across the tech, biotech, and logistics sectors.
Andy Weber
Hon. Andy Weber served as the United States Assistant Secretary of Defense for Nuclear, Chemical & Biological Defense Programs under President Obama.
He has advised leading companies and government agencies in transformative technologies within biology, including DARPA, Ginkgo BioWorks, BioBot Analytics, and NTxBio.
Previous career: U.S. Foreign Service Officer, Office of the Secretary of Defense, Senior Fellow at Harvard's Belfer Center, Head of Global Partnerships at Metabiota, and Deputy Coordinator for Ebola Response, U.S. Department of State.
Andy currently serves as Senior Fellow at the Council on Strategic Risks, Washington DC.
Ole Søeberg
Ole Søeberg runs Nordic Investment Partners, an advisory service for investing, fundraising and strategy sparring built on his 38+ years of experience in global financial markets. Board member in investment related organizations for the past 25 years.
Ole has a successful track record of identifying important growth trends early and investing ahead of the curve as the trend matures.
He has been Chairman of Danish Shareholders Association, board member of Carnegie World Wide, Skagen Funds, TGS Nopec, Precise Biometrics, and AC Vision Fund.
Ole has managed capital for AC Vision Fund and Skagenfunds in Norway as CIO and fund manager since 2011. From 1985 to 2011, he held various roles in equity research, investment management, and Investor Relations with leading Nordic companies such as Alfred Berg, Carnegie TDC, and Tryg Insurance.
Ole holds an MBA from Copenhagen Business School, and completed executive courses at IMD and INSEAD.
Yobbo Meshak
Yobbo Meshak has a successful track record of building companies and fostering collaboration within the biotech and technology industries. As an entrepreneur, he has founded and invested in several early stage business ventures. He has also helped European pharmaceutical companies expand their business in the Asia-Pacific market for over 19 years.
He has facilitated collaborations between companies, private investors, universities, and governmental organizations for the development of innovative technologies.
Yobbo has worked with private equity investors throughout his career, and over the past 3 years alone, raised over $150M in funding across the tech, biotech, and logistics sectors.
Andy Weber
Hon. Andy Weber served as the United States Assistant Secretary of Defense for Nuclear, Chemical & Biological Defense Programs under President Obama.
He has advised leading companies and government agencies in transformative technologies within biology, including DARPA, Ginkgo BioWorks, BioBot Analytics, and NTxBio.
Previous career: U.S. Foreign Service Officer, Office of the Secretary of Defense, Senior Fellow at Harvard’s Belfer Center, Head of Global Partnerships at Metabiota, and Deputy Coordinator for Ebola Response, U.S. Department of State.
Andy currently serves as Senior Fellow at the Council on Strategic Risks, Washington DC.